Singal AG, Kanwal F, Llovet JM (2023) Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol 20(12):864–884. https://doi.org/10.1038/s41571-023-00825-3

Article  PubMed  Google Scholar 

Yang JD, Hainaut P, Gores GJ et al (2019) A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 16(10):589–604. https://doi.org/10.1038/s41575-019-0186-y

Article  PubMed  PubMed Central  Google Scholar 

Cappuyns S, Corbett V, Yarchoan M et al (2024) Critical appraisal of guideline recommendations on systemic therapies for advanced hepatocellular carcinoma: a review. JAMA Oncol 10(3):395–404. https://doi.org/10.1001/jamaoncol.2023.2677

Article  PubMed  PubMed Central  Google Scholar 

Llovet JM, Pinyol R, Kelley RK et al (2022) Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat Cancer 3(4):386–401. https://doi.org/10.1038/s43018-022-00357-2

Article  PubMed  PubMed Central  Google Scholar 

Saha D, Ryan KR, Lakkaniga NR et al (2021) Targeting rearranged during transfection in cancer: a perspective on small-molecule inhibitors and their clinical development. J Med Chem 64(16):11747–11773. https://doi.org/10.1021/acs.jmedchem.0c02167

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Zhang L, Ge T et al (2024) Understanding sorafenib-induced cardiovascular toxicity: mechanisms and treatment implications. Drug Des Devel Ther 18:829–843. https://doi.org/10.2147/DDDT.S443107

Article  PubMed  PubMed Central  Google Scholar 

Zaafar D, Khalil HMA, Rasheed RA et al (2022) Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through inhibition of the TLR4/NLRP3 signaling pathway. PLoS ONE 17(8):e0271631. https://doi.org/10.1371/journal.pone.0271631

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yousefi F, Shabaninejad Z, Vakili S et al (2020) TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Commun Signal 18(1):87. https://doi.org/10.1186/s12964-020-00555-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu CH, Ho YC, Lee WC et al (2024) Sodium-glucose co-transporter-2 inhibitor empagliflozin attenuates sorafenib-induced myocardial inflammation and toxicity. Environ Toxicol 39(11):4844–4858. https://doi.org/10.1002/tox.24362

Article  CAS  PubMed  Google Scholar 

Feroze RA, Leya J, Herron T et al (2020) Clinical and research tools for the study of cardiovascular effects of cancer therapy. J Cardiovasc Transl Res 13(3):417–430. https://doi.org/10.1007/s12265-020-10030-7

Article  PubMed  Google Scholar 

Valzania C, Paccagnella A, Spadotto A et al (2023) Early detection of cancer therapy cardiotoxicity by radionuclide angiography: an update. J Nucl Cardiol 30(5):2104–2111. https://doi.org/10.1007/s12350-023-03202-w

Article  PubMed  Google Scholar 

Sourdon J, Lager F, Viel T et al (2017) Cardiac metabolic deregulation induced by the Tyrosine Kinase receptor inhibitor sunitinib is rescued by Endothelin Receptor antagonism. Theranostics 7(11):2757–2774. https://doi.org/10.7150/thno.19551

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim J, Cho SG, Kang SR et al (2020) Association between FDG uptake in the right ventricular myocardium and cancer therapy-induced cardiotoxicity. J Nucl Cardiol 27(6):2154–2163. https://doi.org/10.1007/s12350-019-01617-y

Article  PubMed  Google Scholar 

Finke D, Heckmann MB, Herpel E et al (2021) Early detection of checkpoint inhibitor-associated myocarditis using (68)Ga-FAPI PET/CT. Front Cardiovasc Med 8:614997. https://doi.org/10.3389/fcvm.2021.614997

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kersting D, Settelmeier S, Mavroeidi IA et al (2022) Shining damaged hearts: immunotherapy-related cardiotoxicity in the spotlight of nuclear cardiology. Int J Mol Sci 23(7):3802. https://doi.org/10.3390/ijms23073802

Article  CAS  PubMed  PubMed Central  Google Scholar 

Minamimoto R (2021) Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT. Jpn J Radiol 39(6):540–557. https://doi.org/10.1007/s11604-021-01097-6

Article  PubMed  PubMed Central  Google Scholar 

Shaghaghi Z, Jalali Zefrei F, Salari A et al (2023) Promising radiopharmaceutical tracers for detection of cardiotoxicity in cardio-oncology. Curr Radiopharm 16(3):171–184. https://doi.org/10.2174/1874471016666230228102231

Article  CAS  PubMed  Google Scholar 

Marini C, Ravera S, Buschiazzo A et al (2016) Discovery of a novel glucose metabolism in cancer: the role of endoplasmic reticulum beyond glycolysis and pentose phosphate shunt. Sci Rep 6:25092. https://doi.org/10.1038/srep25092

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sen S, Kundu BK, Wu HC et al (2013) Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart. J Am Heart Assoc 2(3):e004796. https://doi.org/10.1161/JAHA.113.004796

Article  CAS  PubMed  PubMed Central  Google Scholar 

Octavia Y, Tocchetti CG, Gabrielson KL et al (2012) Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52(6):1213–1225. https://doi.org/10.1016/j.yjmcc.2012.03.006

Article  CAS  PubMed  Google Scholar 

Becker MMC, Arruda GFA, Berenguer DRF et al (2023) Anthracycline cardiotoxicity: current methods of diagnosis and possible role of (18)F-FDG PET/CT as a new biomarker. Cardiooncology 9(1):17. https://doi.org/10.1186/s40959-023-00161-6

Article  PubMed  PubMed Central  Google Scholar 

Cui Y, Wang Y, Wang S et al (2023) Highlighting fibroblasts activation in fibrosis: the state-of-the-art fibroblast activation protein inhibitor PET imaging in cardiovascular diseases. J Clin Med 12(18):6033. https://doi.org/10.3390/jcm12186033

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kelly JM, Babich JW (2022) PET tracers for imaging cardiac function in cardio-oncology. Curr Cardiol Rep 24(3):247–260. https://doi.org/10.1007/s11886-022-01641-4

Article  PubMed  PubMed Central  Google Scholar 

Vogel A, Cervantes A, Chau I et al (2019) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30(5):871–873. https://doi.org/10.1093/annonc/mdy510

Article  CAS  PubMed  Google Scholar 

Goh V, Sarker D, Osmani S et al (2012) Functional imaging techniques in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 39(6):1070–1079. https://doi.org/10.1007/s00259-012-2096-x

Article  CAS  PubMed  Google Scholar 

Zhang J, Jiang S, Li M et al (2023) Head-to-head comparison of (18)F-FAPI and (18)F-FDG PET/CT in staging and therapeutic management of hepatocellular carcinoma. Cancer Imaging 23(1):106. https://doi.org/10.1186/s40644-023-00626-y

Article  PubMed  PubMed Central  Google Scholar 

Lyon AR, López-Fernández T, Couch LS et al (2022) 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO), and the International Cardio-Oncology Society (IC-OS). Eur Heart J 43(41):4229–4361. https://doi.org/10.1093/eurheartj/ehac244

Article  PubMed  Google Scholar